Outlook Therapeutics Reports Financial Results for Fiscal Year 2021 and Provides Corporate Update

NEXT STORY
Medicenna Announces Preliminary Clinical Data Showing Preferential Stimulation of Anti-Cancer Immune Cells with MDNA11 Treatment in the Phase 1/2 ABILITY Study
PREV STORY
The American Academy of Anti-Aging Medicine Leads Healthcare Industry Forward, Hosts Largest Advanced Medical Education Event
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Inventiva’s latest research on odiparcil’s mechanism of action published in leading peer-reviewed scientific journal PLOS ONE

author_avatar
NASDAQ Market News

INNATE PHARMA : NUMBER OF SHARES AND VOTING RIGHTS OF INNATE PHARMA AS AT DECEMBER 4, 2017

NUMBER OF SHARES AND VOTING RIGHTS OF Innate Pharma AS AT December 4, 2017 ...

author_avatar
NASDAQ Market News

CoImmune Announces Collaboration with Top US Cancer Center to Accelerate Development of CAR-CIK Therapies to Treat Solid Tumors

author_avatar
NASDAQ Market News